Company / Total Assets
ARDELYX, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$501.6M
FY2025
5-year range
$149.9M / $501.6M
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#141 of 214
Health Care
What the data says
At $502M, ARDELYX, INC.'s total assets ranks #141 of 214 in the Health Care sector. Total Assets has increased for 4 consecutive years, from $150M in FY2021 to $502M in FY2025.
Based on SEC 10-K filings.
$502M in FY2025 with a 5-year CAGR of +20.0%.
Improved from $298M to $502M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +38.2%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Sector benchmark
#141 of 214 in Health CareTop 66% of 214This company $501.6M Sector average $7.5B
▼
-93.3% below sector average
Key checks
Key Insights
- ARDELYX, INC.'s total assets has grown for 4 consecutive years.
- 5-year CAGR of +20.0%, indicating consistent growth.
- In FY2025, total assets increased 15.1% year-over-year.
- Ranks #141 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $501.6M | +15.1% |
| FY2024 | $435.8M | +46.4% |
| FY2023 | $297.6M | +56.6% |
| FY2022 | $190.1M | +26.8% |
| FY2021 | $149.9M | -25.6% |
| FY2020 | $201.6M | -22.4% |
| FY2019 | $259.8M | +41.7% |
| FY2018 | $183.3M | +16.1% |
| FY2017 | $157.9M | -25.9% |
| FY2016 | $213.1M | +82.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026